Ironwood Pharmaceuticals Files 8-K on Shareholder Vote Matters
Ticker: IRWD · Form: 8-K · Filed: Jun 12, 2025 · CIK: 1446847
| Field | Detail |
|---|---|
| Company | Ironwood Pharmaceuticals Inc (IRWD) |
| Form Type | 8-K |
| Filed Date | Jun 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, filing-update
Related Tickers: IRWD
TL;DR
Ironwood Pharma (IRWD) filed an 8-K on shareholder vote matters. Keep an eye on the outcome.
AI Summary
Ironwood Pharmaceuticals, Inc. filed an 8-K on June 12, 2025, reporting on matters submitted to a vote of security holders as of June 10, 2025. The filing details the company's principal executive offices located at 100 Summer Street, Suite 2300, Boston, MA 02110.
Why It Matters
This filing indicates important corporate actions or decisions that have been put to a vote by Ironwood Pharmaceuticals' shareholders, which could impact the company's future direction.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of matters submitted to a vote, not an announcement of significant financial or operational changes.
Key Players & Entities
- IRONWOOD PHARMACEUTICALS, INC. (company) — Registrant
- June 10, 2025 (date) — Date of Earliest Event Reported
- June 12, 2025 (date) — Date of Report
- 100 Summer Street, Suite 2300 (location) — Principal executive offices
- Boston, Massachusetts (location) — Principal executive offices
- 02110 (location) — Zip code of principal executive offices
FAQ
What specific matters were submitted to a vote of Ironwood Pharmaceuticals' security holders?
The filing states that it is a Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, indicating that matters were submitted to a vote, but the specific details of those matters are not provided in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 10, 2025.
What is the official filing date of this 8-K report?
The official filing date of this 8-K report is June 12, 2025.
Where are Ironwood Pharmaceuticals' principal executive offices located?
Ironwood Pharmaceuticals' principal executive offices are located at 100 Summer Street, Suite 2300, Boston, Massachusetts 02110.
What is the Commission File Number for Ironwood Pharmaceuticals?
The Commission File Number for Ironwood Pharmaceuticals is 001-34620.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding IRONWOOD PHARMACEUTICALS INC (IRWD).